TrialJournal of translational medicine2024

Mixed active metabolites of the SNP-6 series of novel compounds mitigate metabolic dysfunction-associated steatohepatitis and fibrosis: promising results from pre-clinical and clinical trials.

Hsin-Tien Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.